化合物 Topiramate lithium T61145
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 488127-53-3 | ¥17,500.00 | 询底价 |
50 mg | 488127-53-3 | ¥13,800.00 | 询底价 |
25 mg | 488127-53-3 | ¥10,600.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Topiramate lithium
描述: Topiramate lithium (McN 4853) is a wide-ranging antiepileptic compound with GluR5 receptor antagonistic properties. Its mechanism of action involves enhancing GABAergic activity, inhibiting kainate/AMPA receptors, voltage-sensitive sodium and calcium channels, and increasing potassium conductance. Additionally, this compound inhibits carbonic anhydrase. [1][2][3]
体外活性: Topiramate lithium has been believed to be a type of antiepileptic drug that blocks spread of seizures. Thus far, the mechanisms of its actions have been proven to include use-dependent inhibition of voltage-dependent Na+ channels in neurons, potentiation of GABA (γ-amino-butyric acid)-induced Cl- influx, and inhibitory effects on inward currents by antagonizing kainate/alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors [2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
化合物 Topiramate lithium T61145信息由TargetMol中国为您提供,如您想了解更多关于化合物 Topiramate lithium T61145报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途